Unlocking the Future of the Immunohistochemistry (IHC) Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Long-Term Projected Growth Rate for the Immunohistochemistry IHC Market, and What Are the Key Drivers?
There has been robust growth observed in the immunohistochemistry (IHC) market size lately. An increase is projected from $2.58 billion in 2024 to $2.78 billion in 2025, which constitutes an 8.0% compound annual growth rate (CAGR). Factors contributing to this progress during the historic period include the clinical adaptation, development of industry standards, escalation of cancer research, automation advancement in laboratories, and breakthroughs in clinical diagnostics.
The market for immunohistochemistry (IHC) is projected to witness a swift expansion in the coming years, escalating to a size of $4.13 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%. The anticipated growth within this period can be credited to factors such as the entry of fresh market participants, the increasing demand within drug development, the integration of biomedical research, the use in diagnostic applications, and advancements in automation and digitalization. The forecast period is also presumed to witness key trends including the proliferation of multiplex IHC techniques, the incorporation of digital pathology, improvements in antibody specificity, acceleration in automation and standardization, and the technique’s application in biomarker discovery.
What Are the Primary Drivers Supporting the Growth of the immunohistochemistry ihc Market?
The immunohistochemistry (IHC) market is projected to thrive due to the escalating prevalence of chronic diseases. Chronic ailments, defined as medical conditions that persist for more than three months and typically can be managed but not eradicated, can be diagnosed through immunohistochemistry because of its unique attributes, including specificity, sensitivity (for detecting specific antigens), quick results, and others. For example, the Centers for Disease Control and Prevention, a national public health agency in the US, reported in 2022 that roughly 37.3 million people, or 11.3% of the US population, have diabetes. Thus, the amplified prevalence of chronic diseases is propelling the expansion of the immunohistochemistry (IHC) market.
Explore Comprehensive Insights Into The Global Immunohistochemistry IHC Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp
What Are the Leading Organizations Impacting the Immunohistochemistry IHC Market’s Growth?
Major companies operating in the immunohistochemistry (IHC) market include:
• Thermo Fisher Scientific Inc._x000D_
• F. Hoffmann-La Roche AG_x000D_
• The Merck Group_x000D_
• Danaher Corporation_x000D_
• PerkinElmer Inc._x000D_
What Are the Most Prominent Trends Driving Change in the Immunohistochemistry IHC Market?
Leading firms in the immunohistochemistry (IHC) market are striving to improve diagnostic precision by integrating cutting-edge technologies and superior reagents, in order to augment tissue analysis efficiency in diverse clinical and research settings. The advanced Neoflex multiomics mass spectrometry imaging (MSI) system is a sophisticated imaging technology designed for meticulous tissue analysis. This technology allows scientists to move from discovery to clinical utilization via advanced mass spectrometry techniques, especially for accurately mapping biomolecules in tissues. For instance, in June 2024, Bruker Corporation, a US-based entity known for developing and supplying scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for tissue imaging based on mass spectrometry. The Neoflex multiomics mass spectrometry imaging (MSI) system meets the requirement to transition from discovery imaging to clinical tissue research. It includes Bruker’s 10-kHz smartbeam 3D laser, sophisticated imaging sensors, and is compatible with OME-TIFF file output with SCiLS Scope software.
Secure Your Global Immunohistochemistry IHC Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Which Growth-Oriented Segments of the Immunohistochemistry IHC Market Are Leading the Industry’s Development?
The immunohistochemistry (IHC) market covered in this report is segmented –
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits
What Regions Are Leading the Charge in the Immunohistochemistry IHC Market?
North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does the Definition of the Immunohistochemistry IHC Market Include?
Immunohistochemistry (IHC) is the technique in diagnosis that uses antibody-antigen interaction to locate particular proteins and antigens in the tissue section. This interaction is visualized using chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dye.
Browse Through More Similar Reports By The Business Research Company:
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024
Orphan Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: